Next Article in Journal
The Importance of a Diagnostic Pathway in the Diagnosis of Haemoptysis
Previous Article in Journal
Epicardial Fat in Patients with Chronic Obstructive Pulmonary Disease as a Marker of High Cardiovascular Risk
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 86
Issue 6
10.5603/ARM.a2018.0052
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Idiopathic Pulmonary Fibrosis Coexisting with Lung Cancer

by
Michał Zieliński
1,*,
Piotr Sitek
2 and
Dariusz Ziora
1
1
Department of Lung Diseases and Tuberculosis, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Katowice, Poland
2
Pulmonology Department, Public Clinical Hospital No. 1 in Zabrze, Medical University of Silesia in Katowice, Katowice, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2018, 86(6), 319-326; https://doi.org/10.5603/ARM.a2018.0052
Submission received: 3 October 2018 / Revised: 20 December 2018 / Accepted: 20 December 2018 / Published: 30 December 2018

Abstract

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with poor prognosis. Although the underlying mechanisms are not fully understood, IPF is connected with lung cancer development, which farther worsens the prognosis. Various papers report IPF and cancer coexistence in 9.8% to over 50% of patients depending on observation period. Contrary to already established guidelines in the general population, there are no widely accepted recommendations on lung cancer treatment in IPF population. At the same time, various oncologic interventions can result in acute exacerbation of IPF. In this paper authors tried to revise the available data on lung cancer in patients with preexisting IPF.
Keywords: idiopathic pulmonary fibrosis; lung cancer; intersititial pneumonitis idiopathic pulmonary fibrosis; lung cancer; intersititial pneumonitis

Share and Cite

MDPI and ACS Style

Zieliński, M.; Sitek, P.; Ziora, D. Idiopathic Pulmonary Fibrosis Coexisting with Lung Cancer. Adv. Respir. Med. 2018, 86, 319-326. https://doi.org/10.5603/ARM.a2018.0052

AMA Style

Zieliński M, Sitek P, Ziora D. Idiopathic Pulmonary Fibrosis Coexisting with Lung Cancer. Advances in Respiratory Medicine. 2018; 86(6):319-326. https://doi.org/10.5603/ARM.a2018.0052

Chicago/Turabian Style

Zieliński, Michał, Piotr Sitek, and Dariusz Ziora. 2018. "Idiopathic Pulmonary Fibrosis Coexisting with Lung Cancer" Advances in Respiratory Medicine 86, no. 6: 319-326. https://doi.org/10.5603/ARM.a2018.0052

APA Style

Zieliński, M., Sitek, P., & Ziora, D. (2018). Idiopathic Pulmonary Fibrosis Coexisting with Lung Cancer. Advances in Respiratory Medicine, 86(6), 319-326. https://doi.org/10.5603/ARM.a2018.0052

Article Metrics

Back to TopTop